# AERIAL Trial: Antiplatelet Therapy in Heart Transplantation

> **NCT04770012** · PHASE3 · RECRUITING · sponsor: **Ottawa Heart Institute Research Corporation** · enrollment: 135 (estimated)

## Conditions studied

- Cardiac Allograft Vasculopathy
- Heart Transplant

## Interventions

- **DRUG:** Placebo
- **DRUG:** aspirin
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT04770012
- **Lead sponsor:** Ottawa Heart Institute Research Corporation
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-06-28
- **Primary completion:** 2027-03
- **Final completion:** 2029-03
- **Target enrollment:** 135 (ESTIMATED)
- **Last updated:** 2026-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04770012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04770012, "AERIAL Trial: Antiplatelet Therapy in Heart Transplantation". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04770012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*